prikaz prve stranice dokumenta Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.
No public access
Scientific paper - Original scientific paper
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.
Atherosclerosis (Amsterdam), 285 (2019); 135-146. https://doi.org/10.1016/j.atherosclerosis.2019.03.014
(ESC- EORP EUROASPIRE V survey) De Backer, Guy; Jankowski, Piotr; Kotseva, Kornelia; Mirrakhimov, Erkin; Reiner, Željko; Ryden, Lars; Tokgözoğlu, Lale; Wood, David; De Bacquer, Dirk

Cite this document

De Backer, G., Jankowski, P., Kotseva, K., Mirrakhimov, E., Reiner, Ž., Ryden, L. ... De Bacquer, D. (2019). Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.. Atherosclerosis (Amsterdam), 285., 135-146. doi: 10.1016/j.atherosclerosis.2019.03.014

De Backer, Guy, et al. "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.." Atherosclerosis (Amsterdam), vol. 285, 2019, pp. 135-146. https://doi.org/10.1016/j.atherosclerosis.2019.03.014

De Backer, Guy, Piotr Jankowski, Kornelia Kotseva, Erkin Mirrakhimov, Željko Reiner, Lars Ryden, Lale Tokgözoğlu, David Wood and Dirk De Bacquer. "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.." Atherosclerosis (Amsterdam) 285 (2019): 135-146. https://doi.org/10.1016/j.atherosclerosis.2019.03.014

De Backer, G., et al. (2019) 'Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.', Atherosclerosis (Amsterdam), 285, pp. 135-146. doi: 10.1016/j.atherosclerosis.2019.03.014

De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Ryden L, and sur.. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.. Atherosclerosis (Amsterdam) [Internet]. 2019 [cited 2024 December 26];285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014

G. De Backer, et al., "Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.", Atherosclerosis (Amsterdam), vol. 285, pp. 135-146, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:023900. [Accessed: 26 December 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC- EORP EUROASPIRE V survey in 27 countries.
AuthorGuy De Backer
AuthorPiotr Jankowski
AuthorKornelia Kotseva
AuthorErkin Mirrakhimov
AuthorŽeljko Reiner
AuthorLars Ryden
AuthorLale Tokgözoğlu
AuthorDavid Wood
AuthorDirk De Bacquer
CollaborationESC- EORP EUROASPIRE V survey
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
BACKGROUND AND AIMS: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients. METHODS: Standardized methods were used by trained technicians to collect information on 7824 patients from 130 centers in 27 countries, from the medical records and at a visit at least 6 months after hospitalization for a coronary event. All lipid measurements were performed in one central laboratory. Patients were divided into three groups: on high-intensity LDL-C- lowering-drug therapy (LLT), on low or moderate-intensity LLT and on no LLT. RESULTS: At the time of the visit, almost half of the patients were on a high-intensity LLT. Between hospital discharge and the visit, LLT had been reduced in intensity or interrupted in 20.8% of the patients and had been started or increased in intensity in 11.7%. In those who had interrupted LLT or had reduced the intensity, intolerance to LLT and the advice of their physician were reported as the reason why in 15.8 and 36.8% of the cases, respectively. LDL-C control was better in those on a high-intensity LLT compared to those on low or moderate intensity LLT. LDL-C control was better in men than women and in patients with self- reported diabetes. CONCLUSIONS: The results of the EUROASPIRE V survey show that most coronary patients have a less than optimal management of LDL-C. More professional strategies are needed, aiming at lifestyle changes and LLT adapted to the need of the individual patient.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleAtherosclerosis (Amsterdam)
Numberingvol. 285, pp. 135-146
p-ISSN0021-9150
DOIhttps://doi.org/10.1016/j.atherosclerosis.2019.03.014
URN:NBNurn:nbn:hr:184:023900
Publication2019
Document URLhttp://bib.irb.hr/999699
Type of resourceText
Access conditionsClosed access
Terms of useLicence In copyright icon
Created on2022-02-18 12:47:23